The fungus Cunninghamella elegans was used to biotransform 6-nitrochrysene, a mutagen that is a widespread environmental contaminant. After 6 days, 74% of the 3 H-labeled 6-nitrochrysene added had been metabolized to two isomeric sulfate conjugates. These conjugates were separated by high-performance liquid chromatography and identified by UV-visible, 1 H nuclear magnetic resonance, and mass spectral techniques as 6-nitrochrysene 1-sulfate and 6-nitrochrysene 2-sulfate.
Cultures of C. elegans ATCC 36112 were grown as described previously (31) except that 2.0 mg of 6-nitrochrysene, dissolved in 0.5 ml of dimethyl sulfoxide, was added to each culture and to noninoculated controls. All flasks were incubated for an additional 96 h in the dark. Ethyl acetate was used for extraction as previously described (31) .
6-Nitro[U- 3 H]chrysene (specific activity, 2.98 mCi/mmol; radiochemical purity, Ͼ98%) and unlabeled 6-nitrochrysene (purity, 99%) were purchased from Chemsyn Science Laboratories (Lenexa, Kans.). All other chemicals were of reagent grade and the highest purity available.
Biotransformation experiments were conducted by adding 1.58 Ci of 6-nitro [ 3 H]chrysene and 2 mg of unlabeled 6-nitrochrysene to culture flasks. Fungal metabolites of 6-nitrochrysene were separated by high-performance liquid chromatography (HPLC) (28) . The percent metabolism to various products was quantified by fraction collection and liquid scintillation methods (31) . Metabolites were collected from repeated injections; fractions with similar retention times were pooled and concentrated in vacuo. The metabolites that eluted near each other were further purified by HPLC (28) .
UV-visible absorption spectra of the purified metabolites in methanol were determined with a Shimadzu (Kyoto, Japan) model UV-2101PC spectrophotometer. Mass spectral analyses were performed with a Finnigan Corp. (San Jose, Calif.) MAT TSQ 700 mass spectrometer. Samples were dissolved in methanol and analyzed by direct exposure probe-electron ionization-mass spectrometry (DEP-EI-MS). The first quadrupole of the mass spectrometer was scanned from 50 to 650 Da in 1 s. The ion source temperature was 150°C, and the electron energy was 70 V. The DEP current was ramped from 0 to 800 mA at 5 mA/s. Nuclear magnetic resonance (NMR) spectra were recorded in the 1 H configuration at 500.13 MHz on a Bruker Instruments (Billerica, Mass.) AM500 spectrometer at 28°C. Samples were dissolved in deuterated acetone; chemical shifts are reported on the ␦ scale by assigning the residual proton resonance of the deuterated solvent to 2.05 ppm (15) .
Metabolites that were thought to be sulfates were deconjugated by adding equal quantities to two test tubes, each containing 2 ml of 0.2 M Tris-HCl buffer (pH 7.2). To one tube, 3.0 U (210 l) of arylsulfatase (type V; Sigma Chemical Co., St. Louis, Mo.) was added; the second tube served as a control. The products were extracted with ethyl acetate (28) .
When the cultures of C. elegans incubated with 6-nitro[ 3 H] chrysene were extracted, about 40% of the total radioactivity added was recovered in the organic-soluble phase; the remainder was bound to the mycelia. The 3 H-labeled fractions, which were separated by HPLC and detected by liquid scintillation methods, eluted at 7 to 10 min and at 43 min ( Fig. 1) . The elution profile of the ethyl acetate-soluble metabolites formed during incubation of 6-nitrochrysene with C. elegans, with the UV detector at 254 nm ( Fig. 1 ), shows two major peaks, at 8.0 and 9.0 min. The residual 6-nitrochrysene peak eluted at 43.0 min (Fig. 1 ). The kinetics of the disappearance of 6-nitro[ 3 H] chrysene and the appearance of the two labeled metabolites during incubation with C. elegans for 8 days are shown in the Fig. 1 inset. Since 62% of the radioactivity recovered in the organic phase at time zero was found in the 6-nitrochrysene peak, the absolute recovered radioactivity of 6-nitrochrysene was adjusted to 100% to correct for extraction efficiency. At 48 h, the 6-nitrochrysene peak had decreased to about 54% of the radioactivity at time zero, while the two metabolites together accounted for about 36%. At 144 h, metabolites I and II together accounted for 74% of the recovered radioactivity and 26% remained as 6-nitrochrysene (Fig. 1, inset) . Sterile control flasks dosed with 6-nitrochrysene showed no changes.
The structures of metabolites I and II were analyzed by NMR spectroscopy and MS. In the 1 H-NMR analysis (Table  1) , a comparison of the chemical shifts of the protons in metabolites I and II with those in 6-nitrochrysene shows small upfield shifts of the protons ortho to the C-1 and C-2 substitutions, respectively. These chemical shifts are inconsistent with simple phenol substitution but consistent with sulfate conjugation. The absence of aliphatic resonances eliminates the possibility of conjugation with glucose or glucuronic acid. The DEP-EI mass spectra of both metabolites (Table 1) Because the NMR data for metabolites I and II suggested the presence of sulfate groups, metabolites I and II were treated with arylsulfatase and the HPLC, UV-visible, and mass spectral analyses were repeated. The HPLC elution profiles of metabolite I before and after treatment with arylsulfatase show an increase in retention time from 8.0 to 20.5 min. Similarly, the elution profiles of metabolite II before and after treatment with arylsulfatase show an increase in retention time from 9.0 to 21.0 min. The UV spectra of the two metabolites, which were similar to each other before arylsulfatase treatment, had changed to two other similar spectra after treatment. The mass spectra of the arylsulfatase-treated metabolites (data not shown) had molecular and fragment ions characteristic of hydroxy-6-nitrochrysenes. Based on the increases in HPLC retention times after deconjugation with arylsulfatase, on analyses of the deconjugated metabolites by UV-visible spectroscopy and MS, and on analyses of the untreated conjugates by NMR, metabolites I and II were identified as 6-nitrochrysene 1-sulfate and 6-nitrochrysene 2-sulfate, respectively.
The metabolism of PAHs and nitro-PAHs by C. elegans often includes both phase I (oxidation) and phase II (conjugation) steps (4, 26, 37) . C. elegans metabolizes unsubstituted chrysene to the sulfate conjugates of 2-hydroxychrysene and 2,8-dihydroxychrysene (31) . In the present study, C. elegans 
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on August 28, 2017 by guest http://aem.asm.org/ Downloaded from oxidized 6-nitrochrysene to two hydroxylated intermediates, which it then conjugated with sulfate (Fig. 2) . The mechanism presumably involved a cytochrome P-450 monooxygenase reaction (16) to form the 1,2-epoxide, followed by a nonenzymatic rearrangement via a National Institutes of Health shift mechanism (3) to form the two isomeric phenols. Subsequent transfer of sulfate groups formed the conjugates of 6-nitrochrysene, as previously demonstrated with C. elegans for other xenobiotics (4, 6, 23, 37) . The same fungus also transforms 2-and 3-nitrofluoranthenes to the 8-and 9-sulfates (27, 28) ; the nitro group shifts the oxidation to the C-8 and C-9 positions of the 3-nitrofluoranthene molecule (28) . It also forms a sulfate conjugate from 1-hydroxy-6-nitrobenzo[a]pyrene (23) . However, C. elegans forms glucoside conjugates from 6-and 8-hydroxy-1-nitropyrene (5) and from 1-and 3-hydroxy-6-nitrobenzo[a]pyrene. The sulfates and glucosides of PAHs and nitroPAHs are usually considered detoxification products (4, 30) . For several other xenobiotic compounds, however, sulfate conjugation results in bioactivation (18) . In mice, the major activation pathway of 6-nitrochrysene leads through the proximate tumorigen trans-1,2-dihydro-1,2-dihydroxy-6-aminochrysene and then to 1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-6-aminochrysene (14) . The formation of the tumorigenic trans-dihydrodiol can lead to formation of carcinogen-DNA adducts (8, 11, 12, 21) . Human liver and lung tissues also metabolize 6-nitrochrysene to carcinogenic metabolites via ring oxidation and nitroreduction mediated by cytochrome P-450 enzymes (9) . In contrast to the mammalian activation pathways, the formation of sulfate metabolites from 6-nitrochrysene by C. elegans is likely to lead toward detoxification. Previously, C. elegans was shown to reduce the mutagenicity of 1-nitropyrene (5) and several other xenobiotics (2, 7, 26, 30, 37) . Considering that the mammalian metabolism of 6-nitrochrysene forms mutagens and carcinogens, the formation of less toxic phenols and conjugates by fungi is desirable and C. elegans may prove to be useful in the bioremediation of wastes containing nitro-PAHs. (24) 
